Claudia Ordonez, Chief Medical Officer at Keros Therapeutics, Inc. (KROS), sold 1,000 shares at $64.86 ($65K) on 2021-03-11, disclosed to the SEC on 2021-03-15.
Scheduled sale ($65k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.09 | 395 | $25K | 39.2% |
| 2 | $64.86 | 605 | $39K | 60.8% |
| Total | $64.56 avg | 1,000 | $65K | 100% |
| Filing → |
| KROS | SELL | 2021-04-14 | $60K | — | Filing → |
| KROS | SELL | 2021-02-16 | $65K | — | Filing → |